TANG CAPITAL PARTNERS LP - 31 Dec 2024 SCHEDULE 13G/A Report for Marinus Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (MRNS)

Filing Manager: TANG CAPITAL PARTNERS LP
Reporting Manager: TANG CAPITAL MANAGEMENT, LLC
Security: Marinus Pharmaceuticals, Inc. Common Stock, par value $0.001 per share
Symbol: MRNS
Shares outstanding: 54,731,500 shares
Disclosed Ownership: 1,641,945 shares
Ownership: 3%
Form type: SCHEDULE 13G/A
Filing time: 14 Feb 2025, 16:00:04 UTC
Date of event: 31 Dec 2024
SEC: View on sec.gov

Reporting Managers (5)

Name	Ownership	Shares Owned	shared voting power	Signature	Title
TANG CAPITAL MANAGEMENT, LLC	3%	1,641,945	1,641,945	/s/ Kevin Tang	Manager
KEVIN TANG	3%	1,641,945	1,641,945	/s/ Kevin Tang	Self
TANG CAPITAL PARTNERS, LP	2.4%	1,341,945	1,341,945	/s/ Kevin Tang	Manager, Tang Capital Management, LLC, General Partner
TANG CAPITAL PARTNERS III, INC	0.6%	300,000	300,000	/s/ Kevin Tang	Chief Executive Officer
TANG CAPITAL PARTNERS IV, INC	0%	0	0	/s/ Kevin Tang	Chief Executive Officer